Qingbin Song, MD
img_Qingbin Song
ASSISTANT PROFESSOR | Medicine, Nephrology
Integration of the custom database with the GeneTraffic (Microarray) database
Digital data from biological instruments will be automated and transformed into a central database system using the BioExper system, and QTL MATCHMAKER database, a tool that enables high throughput mappings of genes and large scale comparative genomic analysis between Homo sapiens, Mus musculus, and Rattus norvegicus. Applications carried out to date include the development of Animal Inventory and Reagent Management modules.

Development of a Computer Managed Comprehensive Platform (BioExper)
Cutting-edge technology will be employed to develop a web-based platform, including JAVA programming language, XML, Oracle database etc. The system will store research data in a central database system, and captures experimental data at single experimental steps. The system will enable easier and more efficient communication of data between medical researchers and provide a data analysis tool.

Research Interests:

  • Sample tracking and specimen repository management 
  • Next-generation sequencing data analysis
  • Biomedical instruments integration into LIMS
For more information, please visit the Information Technology Laboratory website.

MD, Harbin Medical University

Heilongjiang Health Institute

MS, City University of New York

Albert Einstein College of Medicine

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Song has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.